Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
Xu, Qiaoping, Yuanyuan, Li, Jiejing, Zhu, Jian, Liu, Qingyu, Li, Lingya, Chen, Ying, Luo, Changchen, Shi, Yangling, Li, Wei, Yan
Published in Cost effectiveness and resource allocation (23.02.2021)
Published in Cost effectiveness and resource allocation (23.02.2021)
Get full text
Journal Article
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
XU, Qiaoping, LI, Yuanyuan, ZHU Jiejing, Liu, Jian, LI, Qingyu, Chen, Lingya, LUO, Ying, SHI Changchen, LI, Yangling, YAN, Wei
Published in Cost Effectiveness and Resource Allocation (07.01.2021)
Published in Cost Effectiveness and Resource Allocation (07.01.2021)
Get full text
Web Resource